Robeco Institutional Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3M | Buy |
123,082
+29,433
| +31% | +$5.14M | 0.03% | 326 |
|
|
2025
Q4 | $15.9M | Sell |
93,649
-2,769
| -3% | -$425K | 0.02% | 372 |
|
|
2025
Q3 | $12.7M | Sell |
96,418
-24,497
| -20% | -$2.94M | 0.02% | 411 |
|
|
2025
Q2 | $12.8M | Sell |
120,915
-92,794
| -43% | -$10.1M | 0.02% | 418 |
|
|
2025
Q1 | $26.5M | Buy |
213,709
+12,405
| +6% | +$1.62M | 0.05% | 282 |
|
|
2024
Q4 | $24.8M | Buy |
201,304
+33,948
| +20% | +$4M | 0.05% | 295 |
|
|
2024
Q3 | $18.6M | Sell |
167,356
-19,161
| -10% | -$2.1M | 0.04% | 351 |
|
|
2024
Q2 | $19.9M | Sell |
186,517
-117,593
| -39% | -$12.9M | 0.04% | 317 |
|
|
2024
Q1 | $36.6M | Sell |
304,110
-7,524
| -2% | -$922K | 0.08% | 242 |
|
|
2023
Q4 | $38.3M | Buy |
311,634
+27,582
| +10% | +$3.44M | 0.09% | 219 |
|
|
2023
Q3 | $36.8M | Buy |
284,052
+67,440
| +31% | +$8.99M | 0.1% | 217 |
|
|
2023
Q2 | $26.9M | Buy |
216,612
+83,899
| +63% | +$11.3M | 0.07% | 275 |
|
|
2023
Q1 | $19.4M | Buy |
132,713
+9,061
| +7% | +$1.34M | 0.05% | 320 |
|
|
2022
Q4 | $19.7M | Sell |
123,652
-11,448
| -8% | -$1.68M | 0.06% | 313 |
|
|
2022
Q3 | $18M | Buy |
135,100
+125,332
| +1,283% | +$19.1M | 0.06% | 278 |
|
|
2022
Q2 | $1.52M | Sell |
9,768
-3,196
| -25% | -$492K | ﹤0.01% | 658 |
|
|
2022
Q1 | $2.02M | Buy |
12,964
+491
| +4% | +$71.3K | ﹤0.01% | 640 |
|
|
2021
Q4 | $1.59M | Sell |
12,473
-18,399
| -60% | -$2.42M | ﹤0.01% | 663 |
|
|
2021
Q3 | $4.02M | Sell |
30,872
-78,744
| -72% | -$11.9M | 0.01% | 588 |
|
|
2021
Q2 | $19.5M | Sell |
109,616
-49,243
| -31% | -$8.53M | 0.04% | 368 |
|
|
2021
Q1 | $26.1M | Sell |
158,859
-75,132
| -32% | -$12.4M | 0.06% | 300 |
|
|
2020
Q4 | $38.6M | Sell |
233,991
-34,145
| -13% | -$5.09M | 0.1% | 225 |
|
|
2020
Q3 | $38.2M | Sell |
268,136
-3,884
| -1% | -$482K | 0.12% | 189 |
|
|
2020
Q2 | $30M | Buy |
272,020
+91,932
| +51% | +$10.2M | 0.1% | 220 |
|
|
2020
Q1 | $18M | Buy |
180,088
+67,050
| +59% | +$8.67M | 0.07% | 301 |
|
|
2019
Q4 | $16.9M | Buy |
113,038
+15,246
| +16% | +$2.07M | 0.05% | 379 |
|
|
2019
Q3 | $12.5M | Buy |
97,792
+22,651
| +30% | +$3.04M | 0.04% | 407 |
|
|
2019
Q2 | $10.7M | Buy |
75,141
+64,013
| +575% | +$8.6M | 0.04% | 451 |
|
|
2019
Q1 | $1.59M | Sell |
11,128
-1,747
| -14% | -$228K | 0.01% | 739 |
|
|
2018
Q4 | $1.59M | Sell |
12,875
-9,593
| -43% | -$1.42M | 0.01% | 699 |
|
|
2018
Q3 | $3.78M | Buy |
22,468
+13,237
| +143% | +$2.28M | 0.02% | 598 |
|
|
2018
Q2 | $1.59M | Buy |
9,231
+4,951
| +116% | +$809K | 0.01% | 696 |
|
|
2018
Q1 | $645K | Buy |
4,280
+2,233
| +109% | +$328K | ﹤0.01% | 788 |
|
|
2017
Q4 | $276K | Buy |
+2,047
| New | +$284K | ﹤0.01% | 814 |
|
|
2016
Q4 | – | Sell |
-1,894
| Closed | -$230K | – | 821 |
|
|
2016
Q3 | $230K | Hold |
1,894
| – | – | ﹤0.01% | 755 |
|
|
2016
Q2 | $268K | Hold |
1,894
| – | – | ﹤0.01% | 737 |
|
|
2016
Q1 | $247K | Hold |
1,894
| – | – | ﹤0.01% | 752 |
|
|
2015
Q4 | $266K | Hold |
1,894
| – | – | ﹤0.01% | 755 |
|
|
2015
Q3 | $252K | Hold |
1,894
| – | – | ﹤0.01% | 723 |
|
|
2015
Q2 | $333K | Buy |
1,894
+695
| +58% | +$125K | ﹤0.01% | 713 |
|
|
2015
Q1 | $207K | Sell |
1,199
-9,800
| -89% | -$1.68M | ﹤0.01% | 732 |
|
|
2014
Q4 | $1.8M | Buy |
10,999
+1,199
| +12% | +$199K | 0.01% | 481 |
|
|
2014
Q3 | $1.57M | Sell |
9,800
-174
| -2% | -$26.8K | 0.01% | 489 |
|
|
2014
Q2 | $1.47M | Buy |
9,974
+4,000
| +67% | +$555K | 0.01% | 486 |
|
|
2014
Q1 | $828K | Buy |
+5,974
| New | +$899K | 0.01% | 536 |
|
Other funds holding JAZZ
VPM
VCM
EC
Robeco Institutional Asset Management's JAZZ Position: Q1 2026 in Review
Robeco Institutional Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 31% in Q1 2026, buying an estimated $5.14M and bringing the position to 123,082 shares worth $23.3M. The position accounts for 0.03% of the portfolio, ranked #326.
Robeco Institutional Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 45 quarters since. The position peaked at $38.6M in Q4 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Robeco Institutional Asset Management held 123,082 shares of Jazz Pharmaceuticals worth $23.3M as of Q1 2026.
- Robeco Institutional Asset Management bought 29,433 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.14M.
- Jazz Pharmaceuticals made up 0.03% of Robeco Institutional Asset Management's portfolio in Q1 2026, its #326 holding.
- Robeco Institutional Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 45 quarters since.
- Robeco Institutional Asset Management's Jazz Pharmaceuticals position peaked at $38.6M in Q4 2020.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.